The effect of overweight and obesity on psoriasis patients in Chinese Han population: A hospital-based study

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 1, 2011, Pages 87-91

  Zhang, C ^a   Zhu, K J ^a   Zheng, H F ^a   Cui, Y ^a   Zhou, F S ^a   Chen, Y L ^a   Tang, X F ^a   Li, M ^a   Zhang, F Y ^a   Fan, X ^a   Zuo, X B ^a   Yang, S ^a   Sun, L D ^a   Zhang, X J ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

body mass index; Chinese Han population; clinical feature; obesity; overweight; psoriasis

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBESITY; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS;

BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; HOSPITALS; HUMANS; OBESITY; OVERWEIGHT; PREVALENCE; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 78649984645     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03706.x     Document Type: Article

References (37)

1. Zhang X, Wang H, Te-Shao H, Yang S, Chen S,. The genetic epidemiology of psoriasis vulgaris in Chinese Han. Int J Dermatol 2002; 41: 663-669. (Pubitemid 35252042)
2. Lebwohl M,. Psoriasis. Lancet 2003; 361: 1197-1204.
3. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139.
4. Henseler T, Christophers E,. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
5. Wolk K, Mallbris L, Larsson P, Rosenblad A, Vingard E, Stahle M,. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venereol 2009; 89: 492-497.
6. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
7. Setty AR, Curhan G, Choi HK,. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-1675.
8. Hamminga EA, Van Der Lely AJ, Neumann HAM, Thio HB,. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses 2006; 67: 768-773.
9. Bongiorno MR, Doukaki S, Rizzo D, Aric M,. The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations. J Eur Acad Dermatol Venereol 2010; 24: 92-93.
10. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H,. Prevalence of obesity/adiposity in Japanese psoriasis patients: adiposity is correlated with the severity of psoriasis. J Dermatol Sci 2009; 55: 74-76.
11. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB,. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol 2009; 34: 140-144.
12. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
13. Wu Y,. Overweight and obesity in China. BMJ 2006; 333: 362-363.
14. Christophers E, Sterry W,. Psoriasis. In, Fitzpatrick TBEA, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in General Medicine. McGraw-Hill, Inc., New York, 1993: 489-514.
15. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
16. Langley RG, Ellis CN,. Evaluating psoriasis with Psoriasis Area and Severity Index, psoriasis global assessment, and lattice system physician's global assessment. J Am Acad Dermatol 2004; 51: 563-569.
17. Mallbris L, Larsson P, Bergqvist S, Vingard E, Granath F, Stahle M,. Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 2005; 124: 499-504.
18. Mease PJ,. Psoriatic arthritis assessment and treatment update. Curr Opin Rheumatol 2009; 21: 348-355.
19. Sterry W, Strober BE, Menter A,. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-655.
20. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-1534.
21. Raychaudhuri SP, Gross J,. Psoriasis risk factors: role of lifestyle practices. Cutis 2000; 66: 348-352.
22. Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E,. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig 2004; 16: 753-758.
23. Girolomoni G, Gisondi P,. Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol 2009; 23 (Suppl 1): 3-8.
24. Schon MP, Boehncke WH,. Psoriasis. N Engl J Med 2005; 352: 899-912.
25. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P,. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
26. Naldi L, Addis A, Chimenti S, et al. Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project. Dermatology 2008; 217: 365-373.
27. Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G,. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr 2008; 88: 1242-1247.
28. Rucevic I, Perl A, Barisic-Drusko V, Adam-Perl M,. The role of the low energy diet in psoriasis vulgaris treatment. Coll Antropol 2003; 27 (Suppl 1): 41-48.
29. Curat CA, Wegner V, Sengenes C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
30. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW,. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
31. McMullen E, Gawkrodger DJ,. Physical friction is under-recognized as an irritant that can cause or contribute to contact dermatitis. Br J Dermatol 2006; 154: 154-156.
32. Fantuzzi G,. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919. quiz 920.
33. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H,. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 2008; 159: 1207-1208.
34. Wang Y, Chen J, Zhao Y, Geng L, Song F, Chen HD,. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol 2008; 158: 1134-1135.
35. Sandell LJ,. Obesity and osteoarthritis: is leptin the link? Arthritis Rheum 2009; 60: 2858-2860.
36. Saeki H, Shibata S, Tada Y, Karakawa M, Minatani Y, Tamaki K,. Psoriasis arthropathica associated with severe obesity showing high serum leptin level. J Dermatol 2009; 36: 364-366.
37. Rho YH, Solus J, Sokka T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009; 60: 1906-1914.